Predicting blood clots after lung cancer surgery

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study will follow adults undergoing surgical resection for lung cancer for 30 days after surgery to record perioperative clinical, laboratory, and imaging data. Investigators will identify clinical and surgical risk factors associated with postoperative deep vein thrombosis (DVT) and venous thromboembolism (VTE). Collected data will be used to train and test machine learning models to predict individual patient risk of postoperative VTE. Patients with pre-existing DVT/PE, prolonged anticoagulation, major concurrent surgeries, or severe organ dysfunction will be excluded and no investigational treatments are administered.

Why it matters

Who can join: the full rules

Inclusion Criteria:

1. Age ≥ 18 years
2. Patients undergoing surgical resection for lung cancer
3. Postoperative hospital stay ≥ 48 hours
4. Availability of perioperative clinical, laboratory, and imaging data
5. Willingness to provide informed consent and participate in 30-day follow-up

Exclusion Criteria:

1. Pre-existing deep vein thrombosis (DVT) or pulmonary embolism (PE) before surgery
2. Preoperative or ongoing anticoagulation therapy for ≥ 2 weeks
3. Severe coagulation disorders or bleeding diseases
4. Severe hepatic, renal, or hematologic dysfunction, or uncontrolled systemic infection
5. Concurrent major organ surgery (e.g., cardiac, liver surgery)
6. Pregnancy or lactation
7. Incomplete postoperative follow-up data

Where it's running

• The First Hospital of Jilin University, Department of Thoracic Surgery
  Changchun, Jilin, China Recruiting

Study contacts

• Study coordinator: Wei Liu
• Email: l_w01@jlu.edu.cn
• Phone: 86-13596083366

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Boosting lung cancer screening for patients seen in the emergency department

  This project will test whether giving eligible emergency department patients a facilitated referral plus text reminders helps more people get lung cancer screening.

  Recruiting University of Rochester · Rochester, New York · NCT07287085

• Evaluating and improving diagnostics and management of venous thromboembolism

  This study is trying to find better ways to diagnose and manage blood clots in the veins for older patients who might have deep vein thrombosis or pulmonary embolism.

  Recruiting Johannes Gutenberg University Mainz · Mainz, Rhineland-Palatinate · NCT02156401

• Aspirin vs. rivaroxaban for blood clot prevention in newly diagnosed multiple myeloma

  In newly diagnosed multiple myeloma patients on IMiD-based therapy, this study tests whether aspirin or rivaroxaban is better at preventing blood clots.

  Recruiting Phase 4 The First Affiliated Hospital with Nanjing Medical University · Nanjing, Jiangsu · NCT07907211

• TRiP-cast score test in adults with acute lower-limb injuries requiring immobilization

  This study tests whether the TRiP(cast) score can predict risk of blood clots in adults with acute lower-limb injuries treated as outpatients.

  Recruiting University of Monastir · Monastir · NCT07863115

• Pulmonary Embolism Registry from Emergency Care to Long-Term Follow-Up

  This registry follows adults with acute pulmonary embolism to see how care is given in the real world and what happens over time.

  Recruiting at 16 sites Azienda Ospedaliero-Universitaria Careggi · Bagno a Ripoli, Tuscany and 15 other locations · NCT07855679

• Risk-based lung cancer screening in COPD patients using ML and clinical models

  This study tests whether a PLCOm2012 risk model plus a machine learning model can spot COPD patients at high risk for lung cancer to see if they benefit from low-dose CT screening.

  Recruiting Vejle Hospital · Vejle, Region Syddanmark · NCT07848815

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.